SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-056182
Filing Date
2024-03-01
Accepted
2024-03-01 17:17:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d793902d424b5.htm 424B5 439884
2 EX-FILING FEES d793902dexfilingfees.htm EX-FILING FEES 37334
3 GRAPHIC g793902g09c54.jpg GRAPHIC 46694
4 GRAPHIC g793902g37p47.jpg GRAPHIC 46694
  Complete submission text file 0001193125-24-056182.txt   607157
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-277523 | Film No.: 24711602
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)